Shaun O'Neil - Mar 18, 2022 Form 3 Insider Report for Lucid Diagnostics Inc. (LUCD)

Role
Chief Operating Officer
Signature
/s/ Shaun O'Neil
Stock symbol
LUCD
Transactions as of
Mar 18, 2022
Transactions value $
$0
Form type
3
Date filed
4/6/2023, 05:08 PM
Previous filing
May 1, 2023
Next filing
May 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LUCD Common stock 120K Mar 18, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LUCD Employee stock option (right to buy) Mar 18, 2022 Common stock 50K $3.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of January 7, 2025. Such restricted stock is subject to forfeiture if the requisite service period is not completed.
F2 The option vests in 12 quarterly installments, with first installment vesting March 31, 2022.